December 20, 2010 — Replacing host stem cells with donor-derived cells homozygous for the CCR5 gene variant Δ32 (CCR5Δ32/Δ32) resulted in the HIV viral reservoir being reduced over time, strongly ...

A pioneering study explores CAR-T therapy as a promising solution for HIV, showing positive results in controlling the virus ...

By Deena Beasley May 11 (Reuters) - Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded ...

An HIV patient in Oslo has been in remission for the past five years following a stem cell transplant from his brother, who was found to be resistant to the virus, marking what could only be the 10th ...

A 60-year-old man in Germany has become at least the seventh person with HIV to be announced free of the virus after receiving a stem-cell transplant 1. But the man, who has been virus-free for close ...

Researchers addressed the need for long-term expression of CCR5-specific antibodies to establish protection from HIV using ...

HIV therapy milestone: A small Phase 1 trial found CAR‑T cell therapy kept HIV at low or undetectable levels in some patients after stopping antiretroviral drugs. Personalized medicine surge: Genomic ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

HIV-1 remodels the spatial organization of its co-receptor, CXCR4, on T cell membranes, showing that viral entry requires receptor clustering rather than simple receptor binding.